Introduction

Emjard M 12.5/ 500 is a combination of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor and metformin hydrochloride, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate.Emjard M 12.5/ 500 is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. However, the effectiveness of Emjard M 12.5/ 500 on reducing the risk of cardiovascular death in adults with type 2 diabetes mellitus and cardiovascular disease has not been established.

Uses of Emjard M 12.5/ 500

Emjard M 12.5/ 500 use as a treatment of adults with type 2 diabetes mellitus.

Side effects of Emjard M 12.5/ 500

Nausea
Vomiting
Diarrhea
Headaches
Dizziness
Fatigue
Abdominal pain
Increased urination
Weight loss

How to use Emjard M 12.5/ 500

Take Emjard M 12.5/ 500 in the dose and duration prescribed by your doctor. Swallow it whole. Don't chew, crush, or break it. Emjard M 12.5/ 500 should be taken with food.

How Emjard M 12.5/ 500 works

By blocking SGLT2,Emjard M 12.5/ 500 prevents glucose from being reabsorbed and allows it to be excreted in the urine.Also work by decreasing the production of glucose in the liver and increasing the sensitivity of cells to insulin and lowers blood sugar levels.

What if you forget to take Emjard M 12.5/ 500 ?

If you forget to take yourEmjard M 12.5/ 500 , take them as soon as you remember. If it is almost time for your next dose, skip the missed dose and take it at the usual time. Avoid taking two doses at the same time.

Safety Advice

UNSAFE – Alcohol: It is unsafe to consume Emjard M 12.5/ 500 with alcohol.
UNSAFE – Pregnancy: Emjard M 12.5/ 500 should not be used during pregnancy.
UNSAFE – Breastfeeding: Emjard M 12.5/ 500 should not be used during breastfeeding.
CAUTION – Driving: Emjard M 12.5/ 500 may cause dizziness or orthostatic hypotension (low blood pressure when standing up), which can impair ability to drive.
CONSULT YOUR DOCTOR – Kidney: It is important to talk to your doctor about the risks and benefits of taking Emjard M 12.5/ 500 before starting treatment. Emjard M 12.5/ 500 should not be given to patients with serious kidney disease.
CAUTION – Liver: Emjard M 12.5/ 500 may not be suitable for patients with severe liver impairment.